Soluble syndecan-1 as marker of intestinal inflammation: A preliminary study and evaluation of a new panel of biomarkers for non-invasive prediction of active ulcerative colitis

Martin Floer, Mareike Clausen, Tobias Meister, Richard Vollenberg, Dominik Bettenworth, Phil-Robin Tepasse

Open source

DOI
10.17219/acem/139040
Published
2021-07-20
Container
Advances in Clinical and Experimental Medicine
Publisher
Wroclaw Medical University
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17219/acem/139040,
  title = {Soluble syndecan-1 as marker of intestinal inflammation: A preliminary study and evaluation of a new panel of biomarkers for non-invasive prediction of active ulcerative colitis},
  author = {Martin Floer and Mareike Clausen and Tobias Meister and Richard Vollenberg and Dominik Bettenworth and Phil-Robin Tepasse},
  year = {2021},
  journal = {Advances in Clinical and Experimental Medicine},
  doi = {10.17219/acem/139040},
  url = {https://doi.org/10.17219/acem/139040}
}

RIS

TY  - JOUR
TI  - Soluble syndecan-1 as marker of intestinal inflammation: A preliminary study and evaluation of a new panel of biomarkers for non-invasive prediction of active ulcerative colitis
AU  - Martin Floer
AU  - Mareike Clausen
AU  - Tobias Meister
AU  - Richard Vollenberg
AU  - Dominik Bettenworth
AU  - Phil-Robin Tepasse
PY  - 2021
JO  - Advances in Clinical and Experimental Medicine
DO  - 10.17219/acem/139040
UR  - https://doi.org/10.17219/acem/139040
ER  - 

APA

Floer, M., Clausen, M., Meister, T., Vollenberg, R., Bettenworth, D., & Tepasse, P. (2021). Soluble syndecan-1 as marker of intestinal inflammation: A preliminary study and evaluation of a new panel of biomarkers for non-invasive prediction of active ulcerative colitis. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/139040

Source records